GENETIC AND ACQUIRED PREDICTORS OF POSTTHROMBOTIC SYNDROME IN YOUNG PATIENTS WITH DVT IN THE NORTH-WEST REGION OF RUSSIA

EHA Library, Anna Chechulova, 54566

PREVENTABILITY ASSESSMENT OF ADVERSE DRUG REACTIONS IN ONCOHEMATOLOGIC PATIENTS: HEMATOLOGY CLINICAL JUDGMENT COMPARED TO SCHUMOCK AND THORNTON EXPLICIT CRITERIA

EHA Library, Nicola Stefano Fracchiolla, 54579

The Economic Analysis of Plerixafor in First Line Stem Cell Mobilisation: Individual Patient Costing Analysis of the Liverpool PHANTASTIC Trial

EHA Library, Richard Clark, 54577

PATTERN OF ADVERSE DRUG REACTIONS IN ONCO-HEMATOLOGIC PATIENTS: RESULTS FROM THE ITALIAN PHARMACOVIGILANCE PROJECT NAMED 'FARMAREL'

EHA Library, Nicola Stefano Fracchiolla, 54576

Treatment Patterns of Patients With CLL Including Patterns of Rituximab Use by Clinicians Across Five European Countries

EHA Library, Alan Yong, 54575

DIRECT COST ANALYSIS ABOUT THE THREE CHELATORS FOR THE TREATMENT OF THALASSEMIA PATIENTS WITH CHRONIC IRON OVERLOAD: AN ITALIAN PERSPECTIVE FROM THE MIOT NETWORK

EHA Library, Alessia Pepe, 54574

EFFECT OF FTY720 ON THE SET-PP2A COMPLEX IN ACUTE MYELOID LEUKEMIA. SET BINDING DRUGS HAVE ANTAGONISTIC ACTIVITY

EHA Library, Raffaella Pippa, 55653

RESPONSE TO LISINOPRIL IN PATIENTS WITH SICKLE CELL ANEMIA AND PROTEINURIA

EHA Library, Aamer Aleem, 55651

IRON-INDUCED EPIGENETIC ABNORMALITY OF MOUSE BONE MARROW THROUGH ABERRANT ACTIVATION OF ACONITASE AND ISOCITRATE DEHYDROGENASE WITHOUT GENE MUTATION: ANALYSIS BY HIGH THROUGHPUT SEQUENCER AND GC-MS.

EHA Library, Masayo Yamamoto, 55649

ACCELERATION OF BCR-ABL+ LEUKEMIA INDUCED BY DELETION OF JAK2

EHA Library, Eva Grundschober, 55647

THE NOTCH PATHWAY IS RECURRENTLY MUTATED IN DIFFUSE LARGE B CELL LYMPHOMA ASSOCIATED WITH HEPATITIS C VIRUS INFECTION

EHA Library, Luca Arcaini, 55646

TREATMENT OF IRON DEFICIENCY ANAEMIA OF LATE PREGNANCY WITH A SINGLE INTRAVENOUS IRON POLYMALTOSE OR FERRIC CARBOXYMALTOSE VERSUS ORAL IRON SULPHATE: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY (TIDAL)

EHA Library, Alhossain Khalafallah, 55644

SENSITIVITY COST ANALYSIS OF TYROSINE KINASE INHIBITORS IN PHARMACOECONOMIC MODELING OF CML TREATMENT

EHA Library, Vasily Shuvaev, 54573

HOME CARE MANAGEMENT FOR HEMATOLOGICAL PATIENTS: RESULTS OF A SURVEY CONDUCTED ON A REGIONAL SCALE BY THE R.E.D.E.R. NETWORK

EHA Library, Pierluigi Alfieri, 54572

IS OBINUTUZUMAB COST-EFFECTIVE FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA IN THE UNITED STATES?

EHA Library, Carolina Reyes, 54571

ECONOMIC VALUE CREATED BY ADDING RITUXIMAB TO CHEMOTHERAPY IN THE UNITED STATES FROM 1998-2013

EHA Library, Carolina Reyes, 54569

COST-EFFECTIVENESS OF EDOXABAN, APIXABAN, RIVAROXABAN AND DABIGATRAN VERSUS WARFARIN FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION

EHA Library, Monia Marchetti, 54568

EFFICACY, SAFETY AND CLINICAL MANAGEMENT OF THE NEW GENERATION ORAL ANTICOAGULANTS (NOAS) IN THE CLINICAL PRACTICE: 'THE REAL LIFE COHORT STUDY'.

EHA Library, Pavel Eduardo Olivera Sumire, 54567

COMPARATIVE ANALYSIS OF ADVERSE REACTIONS ARISING FROM THE ADMINISTRATION OF CONVENTIONAL CYTOTOXIC DRUGS AND RECENT TARGETED AGENTS, ALONE OR IN ASSOCIATION, IN ONCOHEMATOLOGIC PATIENTS

EHA Library, Nicola Stefano Fracchiolla, 54580

MORTALITY AND INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AND RELATION TO LABORATORY BIOMARKERS: AN UPDATE OF A SINGLE CENTER STUDY

EHA Library, Mirvat Mattar, 54565

LONG-TERM OUTCOME OF NON-CENTRAL-VENOUS-LINE-RELATED DEEP VEIN THROMBOSES LOCATED AT LOWER LIMBS IN CHILDREN

EHA Library, Helen Pergantou, 54564

SCREENING FOR MALIGNANCY IN PATIENTS WITH UNPROVOKED VENOUS THROMBOEMBOLISM

EHA Library, Smita Sinha, 54563

REDUCTIONS IN VENOUS THROMBOEBOLISM EVENTS, ASSOCIATED WITH RADIOLOGICAL DATA PROVIDING REAL-TIME FEEDBACK TO CLINICIANS ABOUT HOSPITAL ACQUIRED THROMBOSIS, GIVEN INADEQUATE PREVENTATIVE MEASURES

EHA Library, Huw Rowswell, 54562

INFLAMMATORY RESPONSE AMONG PATIENTS WITH SUSPECTED VENOUS THROMBOEMBOLISM

EHA Library, Knut Anders Mosevoll, 54561

THREE YEAR MORTALITY ASSOCIATED WITH VENOUS THROMBOEMBOLISM (VTE): COMPARISON OF HOSPITAL ACQUIRED, COMMUNITY ACQUIRED AND INCIDENTAL FINDINGS

EHA Library, Huw Rowswell, 54560

RETROSPECTIVE AUDIT OF INCIDENCE OF PICC LINE RELATED DEEP VEIN THROMBOSIS IN HAEM-ONCOLOGY PATIENTS

EHA Library, Priya Sriskandarajah, 54559

SPANISH REGISTRY OF THROMBOEMBOLIC DISEASE (TD) RELATED WITH HORMONAL THERAPY, PREGNANCY, OBSTETRICS COMPLICATIONS OR ASSISTED REPRODUCTIVE TECHNIQUES IN WOMEN (ARP): RESULTS OF THE TEAM PROJECT

EHA Library, Amparo Santamaria, 54558

EFFICACY OF REPEAT DUPLEX ULTRASOUND IN PATIENTS WITH SUSPECTED DEEP VENOUS THROMBOSIS

EHA Library, Brian Scholtes, 54557

Examination of Real-World Induction Therapy Among Older Patients with Acute Myeloid Leukemia in the United States

EHA Library, Dacosta Byfield, 54583

WILL SUBSTITUTION OF TKI GENERIC BRING THE CML TREATMENT FUTURE TO THE PAST? PHARMACOECONOMIC MODELING OF CML TREATMENT WITH OWN GENERIC USE EXPERIENCE.

EHA Library, Vasily Shuvaev, 54582

SOCIETAL ECONOMIC BURDEN OF IRON DEFICIENCY INDUCED FATIGUE

EHA Library, Patricia R. Blank, 54581

PATTERNS OF DIFFERING THROMBIN GENERATION AND SENSITIVITY TO THE ANTICOAGULANT ACTIVATED PROTEIN C IN PATIENTS WITH MYELOMA AND MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE.

EHA Library, Maeve Crowley, 54546

EVALUATION OF THE THROMBOSIS TENDENCY IN THALASSEMIA MAJOR PATIENTS WITH THROMBIN GENERATION TEST, PROCOAGULANT PHOSPHOLIPID ACTIVITY AND ENDOTHELIAL MICROPARTICLES LEVELS

EHA Library, Ibrahim Eker, 54547

HAEMATOLOGICAL MORBIDITY IN OBSTETRIC PATIENTS WITH CARDIAC DISEASE

EHA Library, Barry Kevane, 54548

CONSENSUS PAPER ON: 'PLATELET CUT-OFF FOR ANTICOAGULANT THERAPY IN CANCER PATIENTS WITH VENOUS THROMBOEMBOLISM AND THROMBOCYTOPENIA'

EHA Library, Giorgia Saccullo, 54550

A SINGLE CENTRE RETROSPECTIVE ANALYSIS OF THE INCIDENCE OF MAJOR BLEEDING IN OVER 1000 PATIENTS COMMENCED ON RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION AND VENOUS THROMBOEMBOLISM

EHA Library, Stephen Jenkins, 54551

ANTICOAGULANT MANAGEMENT OF PREGNANT WOMEN WITH MECHANICAL HEART VALVES: A RETROSPECTIVE COHORT STUDY

EHA Library, Loes Oskam, 54552

MICROPARTICLE-ASSOCIATED TISSUE FACTOR ACTIVITY IN PATIENTS WITH ACUTE UNPROVOKED DEEP VEIN THROMBOSIS AND DURING THE COURSE OF ONE YEAR

EHA Library, Johannes Thaler, 54553

DEVELOPMENT OF A PHARMACOGENETIC-BASED WARFARIN DOSING ALGORITHM IN BRAZILIAN PATIENTS

EHA Library, Paulo Santos, 54554

CURRENT TRENDS IN VENOUS THROMBOEMBOLISM MANAGEMENT IN AUSTRALIA: INITIAL RESULTS FROM THE VENOUS THROMBOEMBOLISM COHORT STUDY

EHA Library, Naomi Aoki, 54555

IN-VIVO REVERSAL OF THE ANTICOAGULANT EFFECT OF APIXABAN WITH 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE

EHA Library, Y. Whitney Cheung, 54556

EHA19 Chair comments: The Future of Hematological Research in Europe

EHA Library, Ulrich Jäger, 55634

The Roadmap for Research in Hematology in Europe

EHA Library, Andreas Engert, 55635

The Perspective from Personalized Medicine

EHA Library, Mark Lawler, 55636

The Perspective from Horizon 2020

EHA Library, Hele Everaus, 55637

EHA19 Presidential Symposium - Best Abstracts: Introduction

EHA Library, Pieter Sonneveld, 55626

EHA19 Jean Bernard Lifetime Achievement Award

EHA Library, Freda Stevenson, 55627

A single oncogenic Enhancer-Rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia

EHA Library, Stefan Gröschel, 55628

Efficacy of thalidomide in the treatment of severe recurrent epistaxis in hereditary hemorrhagic telangiectasia: results of a prospective phase II clinical trail

EHA Library, Rosangela Invernizzi, 55629

Randomized comparision of Ibrutinib versus Ofatumumab in previously treated chronic Lymphocytic Leukemia / Small Lymphocytic lymphoma: Results from the phase III PCYC-1112 Resonate (TM) Trial

EHA Library, Peter Hillmen, 55630

The KRÜPEL-Like factor 2 (KLF-2) Transcription factor is recurrently mutated in splenic marginal zone Lymphoma

EHA Library, Davide Rossi, 55631

EHA19 Jean Bernard Lifetime Achievement Award: Introduction

EHA Library, Christine Chomienne, 55625

EHA19 EHA-ASH Joint Symposium: Access to Medicines and Fair Pricing: the Cost of Innovative Drugs

EHA Library, Jean-Luc Harousseau, 55623

A phase I study of AG-221, a first in class, potent inhibitor of the IDH2-MUTANT PROTEIN, in patients with IDH2 MUTANT POSITIVE ADVANCED HEMATOLOGIC MALIGNANCIES

EHA Library, Stéphane De Botton, 57760

Ruxolitinib proves superior to best available therapy in a prospective, randomized, phase 3 study (response) in patients with Polycythemia vera resistant to or intolerant of Hydroxyurea

EHA Library, Alessandro M. Vannucchi, 57762

Kids a-long: safety, efficacy, and pharmacokinetics of long-acting recombinant factor VIII FC fusion protein (RFVIIIFC) in previously-treated paediatric subjects with Haemophilia A

EHA Library, Beatrice Nolan, 57763

First interim analysis of a pan-european stop trial using standardized molecular criteria: results of the Euro-Ski trial

EHA Library, Susanne Saussele, 57766

EHA19 Chair comments: EHA-ASH Joint Symposium

EHA Library, Christine Chomienne and Linda Burns, 57615

Treatment of thrombosis in cancer patients

EHA Library, Sabine Eichinger, 55614

MM: From clone to target to therapy

EHA Library, Keith Stewart, 55615

Sexuality, fertility and family planning in hematological diseases

EHA Library, Mairéad Ní Chonghaile, 55610

Old people's diseases in young patients with chronic rare anemias

EHA Library, Michael Michael, 55611

EHA19 Chair comments: Part 2 - The challenges of young patients with old people's diseases

EHA Library, Androulla Eleftheriou, 57769

Panel discussion - Part 1 - Generics in Hematology: The doctors' and patients' perspective

EHA Library, Faculty / Presenters, 57768

The patients' perspective

EHA Library, Sarunas Narbutas, 55608

The hematologists' clinical perspective

EHA Library, Ivana Urosevic, 56795

EHA19 Chair comments: Part 1 - Generics in Hematology: The doctors' and patients' perspective

EHA Library, Jan Geissler, 55604

EHA19 Chair comments: Part 1 - Generics in Hematology: The doctors' and patients' perspective

EHA Library, Androulla Eleftheriou, 55605

Drug quality in generics, substandard drugs, copies – the pharmacologist perspective

EHA Library, Atholl Johnston, 55606

ASSESSMENT OF INFECTION EVENTS IN AZACITIDINE (AZA) TREATMENT FOR MYELODYSPLASTIC SYNDROME (MDS) AND ACUTE MYELOID LEUKEMIA (AML). A SINGLE CENTRE EXPERIENCE.

EHA Library, PILAR ROMERO FERNANDEZ, 54028

AZACITIDINE AND INTENSIVE CHEMOTHERAPY IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA: A META-ANALYSIS

EHA Library, SuJun Gao, 53628

INFECTIONS IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME ON TREATMENT WITH AZACYTIDINE: EXPERIENCE OF A SINGLE CENTER.

EHA Library, Sunil Lakhwani Lakhwani, 54027

ANALYSIS OF PNEUMONIA IN ACUTE LEUKEMIA: A PROSPECTIVE STUDY BY THE 'RETE EMATOLOGICA LOMBARDA' (REL)

EHA Library, Valentina Mancini, 54026

THE CLINICAL SPECTRUM AND OUTCOMES OF HUMAN HERPESVIRUS 6-RELATED INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Livia Hegerova, 54025

PHASE IB STUDY OF PF-04449913, A HEDGEHOG (HH) INHIBITOR, IN COMBINATION WITH LOW-DOSE CYTARABINE OR INTENSIVE CHEMOTHERAPY, IN ACUTE MYELOID LEUKEMIA (AML) OR HIGH-RISK MYELODYSPLASTIC SYNDROME (MDS)

EHA Library, Ashleigh O'Connell, 53625

CLINICAL CHARACTERISTICS AND OUTCOMES OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN RECIPIENTS OF ALLOGENEIC STEM CELL TRANSPLANTS

EHA Library, Desire Gijima, 54024

LOW DOSE GEMTUZUMAB OZOGAMICIN PLUS FLAI AS INDUCTION THERAPY IN CD33-POSITIVE AML. DEFINITIVE RESULTS AND LONG TERM OUTCOME OF A PHASE III MULTICENTER PROSPECTIVE CLINICAL TRIAL (NCT.00909168).

EHA Library, Anna CANDONI, 53624

IMPACT OF NOSOCOMIAL VIRAL INFECTION IN CHILDREN UNDERGOING INTENSIVE CHEMOTHERAPY OR STEM CELL TRANSPLANTATION FOR HEMATOLOGIC OR MALIGNANT DISEASE

EHA Library, Hiroshi Yagasaki, 54023

ACUTE MYELOID LEUKEMIA IN PATIENTS 70 AND ABOVE. AZACITIDINE VERSUS INTENSIVE CHEMOTHERAPY

EHA Library, Adolfo De La Fuente, 53623

TANDEM AUTOLOGOUS STEM CELL TRANSPLANTATION DOESN'T INCREASE THE RISK OF SYMPTOMATIC CYTOMEGALOVIRUS REACTIVATION IN MYELOMA PATIENTS IN THE ERA OF NOVEL AGENTS: A SINGLE INSTITUTION STUDY

EHA Library, Francesco Marchesi, 54022

TREATMENT WITH RADIATION, CHEMOTHERAPY, OR BOTH DEMONSTRATES SIMILAR OUTCOMES IN PATIENTS WITH ISOLATED MYELOID SARCOMA THAT MAY NOT BE DIFFERENT THAN DE NOVO ACUTE MYELOID LEUKEMIA

EHA Library, Faye Feller, 53622

A RETROSPECTIVE ANALYSIS OF CYTOMEGALOVIRUS DISEASE IN PATIENTS WITH MALIGNANT LYMPHOMAS WHO HAVE NOT RECEIVED HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Kazuya Sato, 54021

NOVEL FUNCTION FOR THE RNA BINDING PROTEINS RBM38 AND DND1 IN AML CELL DIFFERENTIATION

EHA Library, Julian Wampfler, 53621

SAFE RITUXIMAB ADMINISTRATION TO NHL PATIENTS WITH CONCOMITANT HBV ACTIVE INFECTION: THE RISK OF HBV REACTIVATION SHOULD NOT PREVENT US TO DELIVER OPTIMAL TREATMENT

EHA Library, Vittorio Ruggero Zilioli, 54020

LOW MST1 HIPPO KINASE EXPRESSION CONTRIBUTES TO DIFFERENTIATION DEFICIENCY IN AML CELLS

EHA Library, Julian Wampfler, 53620

PREVALENCE, CHARACTERISTICS AND MANAGEMENT OF OCCULT HEPATITIS B VIRUS INFECTION (OBI) IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS. MONOCENTRIC EXPERIENCE.

EHA Library, Luca Laurenti, 54019

THE IMPACT OF HEPATITIS B VIRUS (HBV) INFECTION ON PROGNOSIS OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA AND THE OCCURRENCE OF HEPATITIS FLARES AFTER WITHDRAWAL OF PROPHYLACTIC ANTIVIRAL TREATMENT

EHA Library, Man Fai Law, 54018

ROLE OF PROPHYLAXIS WITH LAMIVUDINE IN MAINTENANCE TREATMENT WITH RITUXIMAB IN NON HODGKIN LYMPHOMA CD20+

EHA Library, Claudio Cerchione, 54017

THE CATS (FAM64A) PROTEIN IS IMPORTANT FOR CLONOGENICITY OF THE MONOCITIC LEUKEMIA CELL LINE U937

EHA Library, Isabella Barbutti, 53617

PURE RED CELL APLASIA IN PAEDIATRIC HIV

EHA Library, Rajendra Thejpal, 54016

CHANGING OF PLATELET DERIVED MICROPARTICLES, SCUBE-1 AND IL-1? IN CHILDREN WITH DENGUE INFECTION

EHA Library, Darintr Sosothikul, 54015

ALTERATIONS IN MESENCHYMAL STROMAL PRECURSOR CELLS FROM THE BONE MARROW OF THE ACUTE MYELOID LEUKEMIA PATIENTS: NEWLY DIAGNOSED, AND BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

EHA Library, Irina Shipounova, 53615

VARICELLA-ZOSTER VIRUS INFECTIONS IN IMMUNOCOMPROMISED PATIENTS; COMPARISON OF HEMATOLOGY – ONCOLOGY PATIENTS AND OTHER CHRONIC DISEASES

EHA Library, Asim Yoruk, 54014

MESENCHYMAL STEM CELLS (MSCS) OF AML PATIENTS HARBOR CHROMOSOMAL DEFECTS DISTINCT FROM THOSE OF LEUKEMIC CELLS.

EHA Library, Paolo Bernasconi, 53614

LEUKEMIC STEM CELLS OF ACUTE MYELOID LEUKEMIA PATIENTS CARRYING NPM1 MUTATION ARE CANDIDATES FOR TARGETED IMMUNOTHERAPY

EHA Library, Jochen Greiner, 53613

SERIAL TRANSPLANTATION AND IN VIVO IMAGING OF PATIENT-DERIVED XENOGRAFTS: AN ADVANCED PRECLINICAL MODEL TO STUDY DIVERSE GENETIC AML SUBGROUPS IN MICE

EHA Library, Binje Vick, 53612

CHARACTERIZATION OF RARE ?LPHA-GLOBIN GENE MUTATIONS IN THAILAND

EHA Library, Noppacharn Uaprasert, 54011

THE IKAROS 6 ISOFORM COOPERATES WITH BCR-ABL1 TO INDUCE HUMAN ACUTE MYELOID LEUKEMIA IN XENOGRAFTS

EHA Library, Alexandre , 53611

NON-TRANSFERRIN BOUND IRON REVISITED: NOW THAT ITS POTENTIAL TOXICITY IS ESTABLISHED, HOW CAN ITS MEASUREMENT HELP TO GUIDE CHELATION

EHA Library, Vasilios Berdoukas, 54010

THE MYB-GATA1 FUSION IN THE CONTEXT OF LOW GATA1 EXPRESSION FAVOURS THE BASOPHILIC DIFFERENTIATION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS.

EHA Library, Eric Lippert, 53610